Independent emergence of colistin-resistant Enterobacteriaceae clinical isolates without colistin treatment.

Shudan Chen,Fupin Hu,Xuelian Zhang,Xiaogang Xu,Yang Liu,Demei Zhu,Honghai Wang
DOI: https://doi.org/10.1128/JCM.01233-11
2011-01-01
Journal of Clinical Microbiology
Abstract:As mentioned in some reports, with the spread of Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria, colistin use has reemerged as a treatment of last resort despite its severe nephrotoxicity and neurotoxicity ([7][1]). We conducted a surveillance study of carbapenem-resistant
What problem does this paper attempt to address?